Holistic Integrative Management of Cardiovascular Diseases

doi:10.12114/j.issn.1007-9572.2019.00.462

Abstract

Abstract: Cardiovascular disease has become the leading health killer in China with the increasing morbidity and mortality.There is an urgent need for a new chronic disease management program to reduce the morbidity and mortality of cardiovascular disease and improve its cure rate.Therefore，holistic integrative medicine is just the key because it conforms to the modern bio-psycho-social medical model，integrates the advantages of modern multidisciplinary development and comprehensively manages chronic diseases in multi-faceted ways，especially for the management of cardiovascular disease.This article reviews the current situation of holistic integrative medicine in cardiovascular disease management at home and abroad，puts forward the integrated management of cardiovascular disease，and explores the feasible integrated management mode of cardiovascular disease in China.

Key words: Cardiovascular diseases, Cardiac rehabilitation, Holistic integrative medicine, Dieaese management

摘要： 我国心血管疾病发病率和死亡率不断升高，已成为威胁国民健康的头号杀手，迫切需要新的慢性病管理方案来降低心血管疾病发病率，提高治愈率并降低死亡率，因此整合医学理论进入人们视野。其符合现代的生物-心理-社会医学模式，可整合现代多学科发展优势，多方位综合管理慢性病，尤其适用于心血管疾病的管理。本文就整合医学在心血管疾病管理的国内外现状进行综述，提出心血管疾病的整合管理，探索我国可行的心血管疾病整合管理模式。

关键词: 心血管疾病, 心脏康复, 整合医学, 疾病管理

CHEN Guiying,ZHANG Miaomiao,WU Qunhong. Holistic Integrative Management of Cardiovascular Diseases　[J]. Chinese General Practice, 2020, 23(11): 1368-1371. DOI: 10.12114/j.issn.1007-9572.2019.00.462.
陈桂英,张苗苗,吴群红. 心血管疾病的整合管理[J]. 中国全科医学, 2020, 23(11): 1368-1371. DOI: 10.12114/j.issn.1007-9572.2019.00.462.

References

［1］陈伟伟，高润霖，刘力生，等．《中国心血管病报告2017》概要［J］．中国循环杂志，2018，33（1）：1-8.http：//www.cnki.com.cn/Article/CJFDTotal-ZGXH201801001.htm.
［2］胡大一.非传染性疾病的规律［J］．慢性病学杂志，2018，19（9）：1149-1150．DOI：10.16440/j.cnki.1674-8166.2018.09.001.http：//www.cnki.com.cn/Article/CJFDTotal-YYSO201809001.htm.
［3］MEHTA D.Integrative medicine and cardiovascular disorders［J］．Prim Care，2017，44（2）：351-367．DOI：10.1016/j.pop.2017.02.005.
［4］AGGARWAL M，AGGARWAL B，RAO J.Integrative medicine for cardiovascular disease and prevention［J］．Med Clin North Am，2017，101（5）：895-923．DOI：10.1016/j.mcna.2017.04.007.
［5］THOMAS R J，BALADY G，BANKA G，et al．2018 ACC/AHA clinical performance and quality measures for cardiac rehabilitation：a report of the American College of Cardiology/American Heart Association task force on performance measures［J］．J Am Coll Cardiol，2018，71（16）：1814-1837．DOI：10.1016/j.jacc.2018.01.004.
［6］NEUMANN F J，SOUSA-UVA M，AHLSSON A，et al．2018 ESC/EACTS Guidelines on myocardial revascularization［J］．Eur Heart J，2019，40（2）：87-165．DOI：10.1093/eurheartj/ehy394.
［7］WILLIAMS B，MANCIA G，SPIERING W，et al．2018 ESC/ESH Guidelines for the management of arterial hypertension［J］．Eur Heart J，2018，39（33）：3021-3104．DOI：10.1093/eurheartj/ehy339.
［8］樊代明.整合医学初探［J］．医学争鸣，2012，3（2）：3-12．DOI：10.13276/j.issn.1674-8913.2012.02.003.http：//www.cnki.com.cn/Article/CJFDTotal-DSJY201202005.htm
［9］FAN D M.Holistic integrative medicine：toward a new era of medical advancement［J］．Front Med，2017，11（1）：152-159．DOI：10.1007/s11684-017-0499-6.
［10］孙兴国.服务于人的生命科学和医学工作者必须坚持整体观［J］．中国应用生理学杂志，2015，31（4）：289-294．DOI：10.13459/j.cnki.cjap.2015.04.001.http://www.cnki.com.cn/Article/CJFDTotal-ZGSL201504007.htm.
［11］孙兴国.整体整合生理学医学新理论体系概论Ⅱ：循环调控新视野［J］．中国应用生理学杂志，2015，31（4）：302-307．DOI：10.13459/j.cnki.cjap.2015.04.003.http://www.cnki.com.cn/Article/CJFDTotal-ZGSL201504010.htm.
［12］田海军，肖纯凌，吴玉东.整合医学的临床实践—心血管疾病临床整合治疗的进展［J］．沈阳医学院学报，2018，20（5）：393-395．DOI：10.16753/j.cnki.1008-2344.2018.05.003.http://www.cnki.com.cn/Article/CJFDTotal-SYYX201805009.htm.
［13］胡大一.中国心脏康复的现状与发展思路［J］．中国实用内科杂志，2017，37（7）：581-582．DOI：10.19538/j.nk2017070101.http://www.cnki.com.cn/Article/CJFDTotal-SYNK201707001.htm.
［14］胡盛寿，张浩.从整合医学视角看心血管学科未来发展［J］．医学与哲学，2013，34（5）：19-21.http://www.cnki.com.cn/Article/CJFDTotal-YXZX201303008.htm.
［15］霍勇，李康.整合医学：从心血管病学做起［J］．临床心血管病杂志，2015，31（4）：359-361．DOI：10.13201/j.issn.1001-1439.2015.04.004.
HUO Y，LI K.Integrated medicine：starting from cardiology［J］．Journal of Clinical Cardiology，2015，31（4）：359-361．DOI：10.13201/j.issn.1001-1439.2015.04.004.
［16］PIEPOLI M F，CORRà U，ADAMOPOULOS S，et al．Secondary prevention in the clinical management of patients with cardiovascular diseases.Core components，standards and outcome measures for referral and delivery：a policy statement from the cardiac rehabilitation section of the European Association for Cardiovascular Prevention & Rehabilitation.Endorsed by the Committee for Practice Guidelines of the European Society of Cardiology［J］．Eur J Prev Cardiol，2014，21（6）：664-681．DOI：10.1177/2047487312449597.
［17］池菊芳，郭航远，林辉.心脏康复的管理与服务［J］．中国全科医学，2017，20（20）：2432-2438．DOI：10.3969/j.issn.1007-9572.2017.20.002.
CHI J F，GUO H Y，LIN H.Management and services for cardiac rehabilitation［J］．Chinese General Practice，2017，20（20）：2432-2438．DOI：10.3969/j.issn.1007-9572.2017.20.002.
［18］ANDERSON L，OLDRIDGE N，THOMPSON D R，et al．Exercise-based cardiac rehabilitation for coronary heart disease：cochrane systematic review and meta-analysis［J］．J Am Coll Cardiol，2016，67（1）：1-12．DOI：10.1016/j.jacc.2015.10.044.
［19］LUO N，MERRILL P，PARIKH K S，et al．Exercise training in patients with chronic heart failure and atrial fibrillation［J］．J Am Coll Cardiol，2017，69（13）：1683-1691．DOI：10.1016/j.jacc.2017.01.032.
［20］陈纪言，陈韵岱，韩雅玲，等．经皮冠状动脉介入治疗术后运动康复专家共识［J］．中国介入心脏病学杂志，2016，24（7）：361-369.http：//www.cnki.com.cn/Article/CJFDTotal-ZJXB201607001.htm.
［21］TAN B L，NORHAIZAN M E，LIEW W P P.Nutrients and oxidative stress：friend or foe?［J］．Oxid Med Cell Longev，2018，2018：1-24．DOI：10.1155/2018/9719584.
［22］O'DONNELL M，MENTE A，RANGARAJAN S，et al．Urinary sodium and potassium excretion，mortality，and cardiovascular events［J］．N Engl J Med，2014，371（7）：612-623．DOI：10.1056/NEJMoa1311889.
［23］JARRIN D C，ALVARO P K，BOUCHARD M A，et al．Insomnia and hypertension：a systematic review［J］．Sleep Med Rev，2018，41：3-38．DOI：10.1016/j.smrv.2018.02.003.
［24］CUEVAS A G，WILLIAMS D R，ALBERT M A.Psychosocial factors and hypertension［J］．Cardiology Clinics，2017，35（2）：223-230．DOI：10.1016/j.ccl.2016.12.004.
［25］余建英，董再全，胡嘉玳.高血压病常见心理问题及心理干预研究进展［J］．成都医学院学报，2018，13（3）：378-381，384．DOI：10.3969/j.issn.1674-2257.2018.03.034.http：//www.cnki.com.cn/Article/CJFDTotal-CDYU201803034.htm.
［26］MASSAR S A A，LIU J C J，MOHAMMAD N B，et al．Poor habitual sleep efficiency is associated with increased cardiovascular and cortisol stress reactivity in men［J］．Psychoneuroendocrinology，2017，81：151-156．DOI：10.1016/j.psyneuen.2017.04.013.
［27］DOUGHTY K N，DEL PILAR N X，AUDETTE A，et al．Lifestyle medicine and the management of cardiovascular disease［J］．Curr Cardiol Rep，2017，19（11）：116．DOI：10.1007/s11886-017-0925-z.
［28］张苗苗，颜语，李雪，等．心肺联合康复在心力衰竭康复中的作用［J］．中国实用内科杂志，2019，39（1）：86-89．DOI：10.19538/j.nk2019010116.http://www.cnki.com.cn/Article/CJFDTotal-SYNK201901019.htm.
［29］NETO M G，MARTINEZ B P，CONCEI??O C S，et al．Combined exercise and inspiratory muscle training in patients with heart failure：a systematic review and meta-analysis［J］．J Cardiopulm Rehabil Prev，2016，36（6）：395-401．DOI：10.1097/HCR.0000000000000184.
［30］EVANS R A，SINGH S J，COLLIER R，et al．Generic，symptom based，exercise rehabilitation；integrating patients with COPD and heart failure［J］．Respir Med，2010，104（10）：1473-1481．DOI：10.1016/j.rmed.2010.04.024.
［31］张杰，郭航远，池菊芳.中西医结合在心脏康复中的优势分析［J］．中国全科医学，2019，22（12）：1392-1395．DOI：10.12114/j.issn.1007-9572.2019.00.015.
ZHANG J，GUO H Y，CHI J F.Advantage analysis of Chinese and Western medicine integration in cardiac rehabilitation［J］．Chinese General Practice，2019，22（12）：1392-1395．DOI：10.12114/j.issn.1007-9572.2019.00.015.
［32］GAO Z Y，QIU Y，JIAO Y，et al．Analysis on outcome of 3537 patients with coronary artery disease：integrative medicine for cardiovascular events［J］．Evid Based Complement Alternat Med，2013，2013：162501．DOI：10.1155/2013/162501.
［33］ZHANG P Y.Advantages，disadvantages，and trend of integrative medicine in the treatment of heart failure［J］．Cell Biochem Biophys，2015，72（2）：363-366．DOI：10.1007/s12013-014-0466-7.
［34］中国中医药研究促进会中西医结合心血管病预防与康复专业委员会，李瑞杰，史大卓，等．稳定性冠心病中西医结合康复治疗专家共识［J］．中西医结合心脑血管病杂志，2019，17（3）：321-329.http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zxyjhxnxgbzz201903002.

[1]	YU Xinyan, ZHAO Jun, ZHAO Xiaoye, JIANG Qingru, CHEN Yatian, WANG Yan, ZHANG Haicheng. Application of Mobile Smart Healthcare in the Prevention and Control of Cardiovascular Diseases in Elderly Patients with Chronic Diseases in Primary Care [J]. Chinese General Practice, 2023, 26(33): 4167-4172.
[2]	PAN Yaojia, WANG Weiqiang, YI Weizhuo, GAO Bing, FU Fanglin, HAN Zheng, SUN Meng, DONG Yaqin, GU Huaicong. Relationship between Triglyceride-glucose Index and Risk of Cardiovascular Diseases in Middle-aged Obese Residents of Different Genders [J]. Chinese General Practice, 2023, 26(29): 3628-3635.
[3]	LIU Jingtao, SU He, QIN Xiaojin, LAN Yunxia, ZHANG Jinzhi. Guidelines on Cardiac Rehabilitation in Patients with Coronary Heart Disease: a Systematic Review [J]. Chinese General Practice, 2023, 26(19): 2323-2331.
[4]	CHEN Yilin, LIN Ping, HAN Yongkui, WANG Yini. Research on the Construction of Adherence and Its Influencing Factors of Patients with Percutaneous Coronary Intervention in Phase Ⅰ Cardiac Rehabilitation [J]. Chinese General Practice, 2023, 26(18): 2209-2216.
[5]	LIU Taotao, LI Tianrong, WANG Xue, CHEN Jiameng, SHUAI Zhiqin, LI Lisheng, XU Shangfu. Nanoparticle- and Exosome-based Targeted Drug Delivery Systems Used in the Diagnosis and Treatment of Atherosclerosis: Opportunities and Challenges [J]. Chinese General Practice, 2023, 26(08): 903-910.
[6]	WU Changyong, BAO Suli, XU Fei, PENG Yunzhu. Latest Advances in Exercise-induced Autophagy in Improving Cardiovascular Disease Prognosis [J]. Chinese General Practice, 2023, 26(05): 629-634.
[7]	ZHANG Haicheng, YU Xinyan, WANG Hongyu, XUE Tao, LIAO Xiaoyang, FAN Yongmei, ZHANG Qinghong. Discussion on the Difficulties and Bottlenecks in the Management of Remote ECG-based Screening for Cardiovascular Disease Risk in Hierarchical Diagnosis and Treatment [J]. Chinese General Practice, 2023, 26(05): 525-531.
[8]	WANG Zhe, ZHAO Haibin, WANG Guoliang, MA Xiaojuan, YIN Huijun. Complete Revascularization for Acute Myocardial Infarction and Multivessel Disease: an Overview of Systematic Reviews [J]. Chinese General Practice, 2023, 26(02): 142-153.
[9]	TANG Zhaoyun, HE Yang, CHEN Cong, YANG Xiaodan, WU Xinhua, LIU Hong. Risk Assessment of Ischemic Cardiovascular Disease in Rural Naxi Population in Low-to-high Altitudes [J]. Chinese General Practice, 2022, 25(36): 4522-4527.
[10]	SUN Zhenzhen, LIU Huanhuan, CHEN Kaining, LOU Qingqing. New Advances in the Value of the Normal Urinary Albumin as a Predictor of Multiple Diseases [J]. Chinese General Practice, 2022, 25(33): 4191-4195.
[11]	JIA Siqi, WANG Di, LU Yan, JIA Yongping. Effects of High-intensity Interval Training on Cardiac Structure and Function in a Rat Model of Myocardial Infarction [J]. Chinese General Practice, 2022, 25(33): 4159-4167.
[12]	LIAO Jia, WEI Shuangyi, LIU Gang. Overview and Trends of Premature Deaths Due to Four Major Noncommunicable Diseases among Shenzhen Permanent Residents, 2014-2020 [J]. Chinese General Practice, 2022, 25(32): 4085-4090.
[13]	Fang HE, Fulan WANG, Liling XIE, Shuya LING, Mingchao XIAO. Application of TeamSTEPPS in the Management of Out-of-hospital Medication Safety for Patients with Chronic Heart Failure [J]. Chinese General Practice, 2022, 25(30): 3768-3774.
[14]	Xu CHEN, Hanxiong LIU, Xiuqiong YU, Lianchao CHENG, Lingyao QI, Siqi YANG, Yan LUO, Lin CAI. Total Occlusion of the Culprit Artery in Non-ST-segment Elevation Acute Coronary Syndrome: an Analysis of the Influencing Factors and Long-term Outcome Following Percutaneous Coronary Intervention [J]. Chinese General Practice, 2022, 25(27): 3365-3372.
[15]	Ziao RUI, Dongpu DAI, Yingying GUO, Shuo PANG, Yuanhang ZHOU, Yang DU, Xiaoyan ZHAO, Jianzeng DONG. Efficacy and Related Inflencing Factors of Intra-aortic Balloon Counterpulsation Combined with Extracorporeal Membrane Oxygenation in Patients with Acute Myocardial Infarction and Cardiogenic Shock [J]. Chinese General Practice, 2022, 25(21): 2597-2604.